Literature DB >> 19187859

White matter lesions in spastic paraplegia with mutations in SPG5/CYP7B1.

Roberta Biancheri1, Marianna Ciccolella, Andrea Rossi, Alessandra Tessa, Denise Cassandrini, Carlo Minetti, Filippo M Santorelli.   

Abstract

Hereditary spastic paraplegias (HSPs) are relatively frequent disorders presenting great genetic heterogeneity. The recent identification of mutations in SPG5/CYP7B1 in six autosomal recessive kindred linked to the SPG5 locus on chromosome 8q prompted us to test the relative frequency of SPG5/CYP7B1 variants in 12 families and in sporadic HSP patients by high-resolution melting screening combined with direct sequencing. We present two patients who harbored three mutations (including two novel variants) in SPG5/CYP7B1 and white matter involvement evidenced at brain MRI. In HSP patients in whom no other genes were mutated, screening of SPG5/CYP7B1 seems to have a low diagnostic yield in autosomal recessive (8%) and sporadic (<1%) cases, even in those with complicated clinical features.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187859     DOI: 10.1016/j.nmd.2008.10.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  14 in total

1.  Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.

Authors:  Ludger Schöls; Tim W Rattay; Peter Martus; Christoph Meisner; Jonathan Baets; Imma Fischer; Christine Jägle; Matthew J Fraidakis; Andrea Martinuzzi; Jonas Alex Saute; Marina Scarlato; Antonella Antenora; Claudia Stendel; Philip Höflinger; Charles Marques Lourenco; Lisa Abreu; Katrien Smets; Martin Paucar; Tine Deconinck; Dana M Bis; Sarah Wiethoff; Peter Bauer; Alessia Arnoldi; Wilson Marques; Laura Bannach Jardim; Stefan Hauser; Chiara Criscuolo; Alessandro Filla; Stephan Züchner; Maria Teresa Bassi; Thomas Klopstock; Peter De Jonghe; Ingemar Björkhem; Rebecca Schüle
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

Review 2.  Disorders of bile acid synthesis.

Authors:  Peter Theodore Clayton
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

3.  Genetic connections between neurological disorders and cholesterol metabolism.

Authors:  Ingemar Björkhem; Valerio Leoni; Steve Meaney
Journal:  J Lipid Res       Date:  2010-05-13       Impact factor: 5.922

4.  White Matter Alterations in Spastic Paraplegia Type 5: A Multiparametric Structural MRI Study and Correlations with Biochemical Measurements.

Authors:  Y Liu; Z Ye; J Hu; Z Xiao; F Zhang; X Yang; W Chen; Y Fu; D Cao
Journal:  AJNR Am J Neuroradiol       Date:  2021-11-18       Impact factor: 3.825

Review 5.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

Review 6.  CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions.

Authors:  Ashlee R Stiles; Jeffrey G McDonald; David R Bauman; David W Russell
Journal:  J Biol Chem       Date:  2009-08-16       Impact factor: 5.157

Review 7.  Cytochromes p450: roles in diseases.

Authors:  Irina A Pikuleva; Michael R Waterman
Journal:  J Biol Chem       Date:  2013-04-30       Impact factor: 5.157

8.  EBI2 receptor regulates myelin development and inhibits LPC-induced demyelination.

Authors:  Aleksandra Rutkowska; Andreas W Sailer; Kumlesh K Dev
Journal:  J Neuroinflammation       Date:  2017-12-16       Impact factor: 8.322

9.  Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Liver Res       Date:  2020-06-03

10.  Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1.

Authors:  Roberto Di Fabio; Christian Marcotulli; Alessandra Tessa; Luca Leonardi; Eugenia Storti; Francesco Pierelli; Filippo M Santorelli; Carlo Casali
Journal:  J Neurol       Date:  2014-02-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.